Zhongliu Fangzhi Yanjiu (Mar 2022)

Review of Development of Emerging Clinical Antitumor Therapeutics

  • ZHANG Wenqing,
  • WU Jing,
  • XIE Di,
  • SHI Xuecong,
  • HU Hankun

DOI
https://doi.org/10.3971/j.issn.1000-8578.2022.21.1034
Journal volume & issue
Vol. 49, no. 3
pp. 176 – 181

Abstract

Read online

With the continuous progress of tumor treatment methods in recent years, more and more emerging antitumor drugs have been approved to market and put into clinical use. In addition, some treatments that are in clinical trials such as gene therapy are also continuously making new breakthroughs. In this review, we mainly give a brief introduction to the novel antineoplastic therapies that have been clinically used in recent years, as well as the ones with remarkable efficacy and are expected to be approved for marketing.

Keywords